PIRS - Pieris Pharmaceuticals EPS misses by $0.13 misses on revenue November, 04 2020 07:05 AM Pieris Pharmaceuticals Inc. Pieris Pharmaceuticals (PIRS): Q3 GAAP EPS of -$0.26 misses by $0.13.Revenue of $2.94M (-80.6% Y/Y) misses by $8.78M.Press Release For further details see: Pieris Pharmaceuticals EPS misses by $0.13, misses on revenue